[HTML][HTML] Estimating risk of antidepressant withdrawal from a review of published data

MA Horowitz, A Framer, MP Hengartner, A Sørensen… - CNS drugs, 2023 - Springer
Adaptation of the brain to the presence of a drug predicts withdrawal on cessation. The
outcome of adaptation is often referred to as 'physical dependence'in pharmacology, as …

Machine learning based approaches for clinical and non-clinical depression recognition and depression relapse prediction using audiovisual and EEG modalities: A …

S Yasin, A Othmani, I Raza, SA Hussain - Computers in Biology and …, 2023 - Elsevier
Mental disorders are rapidly increasing each year and have become a major challenge
affecting the social and financial well-being of individuals. There is a need for phenotypic …

[HTML][HTML] Designing withdrawal support services for antidepressant users: patients' views on existing services and what they really need

J Read, J Moncrieff, MA Horowitz - Journal of Psychiatric Research, 2023 - Elsevier
Abstract Background Public Health England has recommended that services be put in place
to support people who choose to withdraw from antidepressants because of a current gap …

Outcomes of hyperbolic tapering of antidepressants

J van Os, PC Groot - Therapeutic Advances in …, 2023 - journals.sagepub.com
Background: In patients attempting to discontinue their antidepressant medication, there
have been no prospective studies on patterns of withdrawal as a function of the rate of …

Description of antidepressant withdrawal symptoms in clinical practice guidelines on depression: A systematic review

A Sørensen, KJ Jørgensen, K Munkholm - Journal of Affective Disorders, 2022 - Elsevier
Background Antidepressant withdrawal symptoms may mimic symptoms of depression
relapse and can be challenging for patients when tapering or discontinuing antidepressants …

Antidepressant discontinuation syndrome: A state-of-the-art clinical review

M Fornaro, CI Cattaneo, D De Berardis… - European …, 2023 - Elsevier
Antidepressant drugs are prescribed to patients with depressive, anxiety disorders, and
other conditions. Evidence about antidepressant discontinuation syndrome (ADS) and …

Moving from serotonin to serotonin-norepinephrine enhancement with increasing venlafaxine dose: clinical implications and strategies for a successful outcome in …

A Fagiolini, N Cardoner, S Pirildar… - Expert Opinion on …, 2023 - Taylor & Francis
Introduction Mental health disorders, especially depressive and anxiety disorders, are
associated with substantial health-related burden. While the second-generation …

[HTML][HTML] Discontinuation of psychotropic medication: a synthesis of evidence across medication classes

CH Vinkers, RW Kupka, BW Penninx, HG Ruhé… - Molecular …, 2024 - nature.com
Pharmacotherapy is an effective treatment modality across psychiatric disorders.
Nevertheless, many patients discontinue their medication at some point. Evidence-based …

Discontinuation symptoms of antidepressants

G Lewis, G Lewis - The Lancet Psychiatry, 2024 - thelancet.com
The presence of discontinuation symptoms when patients stop taking antidepressants has
sparked heated discussion, both on social media and in the general public press. In the …

[HTML][HTML] The need for antidepressant withdrawal support services: recommendations from 708 patients

J Read, S Lewis, M Horowitz, J Moncrieff - Psychiatry Research, 2023 - Elsevier
Approximately half of the tens of millions of people currently taking antidepressants will
experience withdrawal symptoms when they try to reduce or come off them. Nearly half of …